Neurogenetics, Part II, Volume 148, the latest release in the Handbook of Clinical Neurology, provides the latest information on the genetic methodologies that are having a significant impact on the study of neurological and psychiatric disorders. Using genetic science, researchers have identified over 200 genes that cause or contribute to neurological disorders. Still an evolving field of study, defining the relationship between genes and neurological and psychiatric disorders is expected to dramatically grow in scope. Part II builds on the foundation of Part I, expanding the coverage to dementias, paroxysmal disorders, neuromuscular disorders, white matter and demyelination diseases, cerebrovascular diseases, adult psychiatric disorders and cancer and phacomatoses.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Handbook of Clinical Neurology 3rd Series - p. v 6. Foreword - p. vii 7. Preface - p. ix 8. Contributors - p. xi 9. Section V: Dementias - p. xi 10. Chapter 26: The genetic landscape of Alzheimer disease - p. xi 11. Chapter 27: Frontotemporal dementia - p. 408 12. Chapter 28: The genetics of dementia with Lewy bodies - p. 430 13. Chapter 29: Prion disease - p. 440 14. Section VI: Paroxysmal disorders - p. 464 15. Chapter 30: Genetics of epilepsy - p. 464 16. Chapter 31: Genetics of migraine - p. 491 17. Chapter 32: Periodic paralysis - p. 503 18. Chapter 33: Episodic ataxias - p. 520 19. Chapter 34: Disorders of sleep and circadian rhythms - p. 529 20. Section VII: Neuromuscular disorders - p. 538 21. Chapter 35: Facioscapulohumeral muscular dystrophy - p. 538 22. Chapter 36: The genetics of congenital myopathies - p. 548 23. Chapter 37: Genetic basis and phenotypic features of congenital myasthenic syndromes - p. 564 24. Chapter 38: Spinal muscular atrophy - p. 589 25. Chapter 39: Emerging understanding of the genotype–phenotype relationship in amyotrophic lateral sclerosis - p. 601 26. Chapter 40: Spinal and bulbar muscular atrophy - p. 623 27. Chapter 41: Hereditary spastic paraplegia - p. 632 28. Chapter 42: Neuropathy - p. 652 29. Section VIII: Diseases of white matter and demyelination - p. 665 30. Chapter 43: The spectrum of adult-onset heritable white-matter disorders - p. 665 31. Chapter 44: Alexander disease - p. 692 32. Chapter 45: Neurogenetics of Pelizaeus–Merzbacher disease - p. 700 33. Chapter 46: Multiple sclerosis - p. 722 34. Section IX: Cerebrovascular diseases - p. 730 35. Chapter 47: CADASIL - p. 730 36. Section X: Major adult psychiatric disorders - p. 743 37. Chapter 48: Neuroepigenetics and addiction - p. 743 38. Chapter 49: Genetic susceptibility in obsessive-compulsive disorder - p. 765 39. Section XI: Cancer and phakomatoses - p. 781 40. Chapter 50: Brain cancer genomics and epigenomics - p. 781 41. Chapter 51: Neurofibromatosis type 1 - p. 797 42. Chapter 52: Tuberous sclerosis complex - p. 811 43. Chapter 53: Von Hippel–Lindau disease and Sturge–Weber syndrome - p. 822 44. Index - p. pgI-1
Neurogenetics, Part II, Volume 148, the latest release in the Handbook of Clinical Neurology, provides the latest information on the genetic methodologies that are having a significant impact on the study of neurological and psychiatric disorders. Using genetic science, researchers have identified over 200 genes that cause or contribute to neurological disorders. Still an evolving field of study, defining the relationship between genes and neurological and psychiatric disorders is expected to dramatically grow in scope. Part II builds on the foundation of Part I, expanding the coverage to dementias, paroxysmal disorders, neuromuscular disorders, white matter and demyelination diseases, cerebrovascular diseases, adult psychiatric disorders and cancer and phacomatoses.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Handbook of Clinical Neurology 3rd Series - p. v 6. Foreword - p. vii 7. Preface - p. ix 8. Contributors - p. xi 9. Section V: Dementias - p. xi 10. Chapter 26: The genetic landscape of Alzheimer disease - p. xi 11. Chapter 27: Frontotemporal dementia - p. 408 12. Chapter 28: The genetics of dementia with Lewy bodies - p. 430 13. Chapter 29: Prion disease - p. 440 14. Section VI: Paroxysmal disorders - p. 464 15. Chapter 30: Genetics of epilepsy - p. 464 16. Chapter 31: Genetics of migraine - p. 491 17. Chapter 32: Periodic paralysis - p. 503 18. Chapter 33: Episodic ataxias - p. 520 19. Chapter 34: Disorders of sleep and circadian rhythms - p. 529 20. Section VII: Neuromuscular disorders - p. 538 21. Chapter 35: Facioscapulohumeral muscular dystrophy - p. 538 22. Chapter 36: The genetics of congenital myopathies - p. 548 23. Chapter 37: Genetic basis and phenotypic features of congenital myasthenic syndromes - p. 564 24. Chapter 38: Spinal muscular atrophy - p. 589 25. Chapter 39: Emerging understanding of the genotype–phenotype relationship in amyotrophic lateral sclerosis - p. 601 26. Chapter 40: Spinal and bulbar muscular atrophy - p. 623 27. Chapter 41: Hereditary spastic paraplegia - p. 632 28. Chapter 42: Neuropathy - p. 652 29. Section VIII: Diseases of white matter and demyelination - p. 665 30. Chapter 43: The spectrum of adult-onset heritable white-matter disorders - p. 665 31. Chapter 44: Alexander disease - p. 692 32. Chapter 45: Neurogenetics of Pelizaeus–Merzbacher disease - p. 700 33. Chapter 46: Multiple sclerosis - p. 722 34. Section IX: Cerebrovascular diseases - p. 730 35. Chapter 47: CADASIL - p. 730 36. Section X: Major adult psychiatric disorders - p. 743 37. Chapter 48: Neuroepigenetics and addiction - p. 743 38. Chapter 49: Genetic susceptibility in obsessive-compulsive disorder - p. 765 39. Section XI: Cancer and phakomatoses - p. 781 40. Chapter 50: Brain cancer genomics and epigenomics - p. 781 41. Chapter 51: Neurofibromatosis type 1 - p. 797 42. Chapter 52: Tuberous sclerosis complex - p. 811 43. Chapter 53: Von Hippel–Lindau disease and Sturge–Weber syndrome - p. 822 44. Index - p. pgI-1
